{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T23:53:01Z","timestamp":1781826781357,"version":"3.54.5"},"reference-count":6,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1053\/j.ajkd.2026.03.035","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T01:00:17Z","timestamp":1775782817000},"page":"880-881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["In Reply to \u201cUnmasking the Survival Benefit: Vascular Fragility and Selection Bias in Dialysis Anticoagulation\u201d and \u201cApixaban Initiation in Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation\u201d"],"prefix":"10.1053","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5272-425X","authenticated-orcid":false,"given":"Wolfgang C.","family":"Winkelmayer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara I.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1053\/j.ajkd.2026.03.035_bib1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1053\/j.ajkd.2025.10.009","article-title":"Effectiveness and safety of apixaban initiation following newly-diagnosed atrial fibrillation in patients with kidney failure on hemodialysis","volume":"87","author":"Winkelmayer","year":"2026","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2026.03.035_bib2","doi-asserted-by":"crossref","DOI":"10.1053\/j.ajkd.2025.12.009","article-title":"Apixaban initiation in hemodialysis patients with newly diagnosed atrial fibrillation","author":"Lu","year":"2026","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2026.03.035_bib3","doi-asserted-by":"crossref","DOI":"10.1053\/j.ajkd.2025.12.008","article-title":"Unmasking the survival benefit: vascular fragility and selection bias in dialysis anticoagulation","author":"Wang","year":"2026","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2026.03.035_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/sdi.12637","article-title":"Predicting in a predicament: stroke and hemorrhage risk prediction in dialysis patients with atrial fibrillation","volume":"31","author":"Molnar","year":"2018","journal-title":"Semin Dial"},{"issue":"12","key":"10.1053\/j.ajkd.2026.03.035_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae347","article-title":"Prediction models for ischemic stroke and bleeding in dialysis patients: a systematic review and meta-analysis","volume":"17","author":"Travlos","year":"2024","journal-title":"Clin Kidney J"},{"issue":"15","key":"10.1053\/j.ajkd.2026.03.035_bib6","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/CIRCULATIONAHA.118.035418","article-title":"Outcomes associated with apixaban use in patients with end-stage kidney disease and atrial fibrillation in the United States","volume":"138","author":"Siontis","year":"2018","journal-title":"Circulation"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638626008401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638626008401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T23:25:04Z","timestamp":1781825104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638626008401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":6,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0272638626008401"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2026.03.035","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In Reply to \u201cUnmasking the Survival Benefit: Vascular Fragility and Selection Bias in Dialysis Anticoagulation\u201d and \u201cApixaban Initiation in Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation\u201d","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2026.03.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}